Established in 1970, Candela is a leading US-based global medical aesthetic device company with headquarters in Marlborough, Massachusetts. The company's technologies enable physicians to provide advanced energy-based solutions for a broad range of medical-aesthetic applications including treatment of benign vascular and pigmented lesions, scar revision, facial resurfacing, wrinkle reduction, acne, spider veins, cellulite reduction, body shaping, gynecological conditions, and tattoo and hair removal.
GentleMax Pro Plus® launched
Higher fluences, larger spot sizes and shorter pulse durations.
Frax Pro® system introduced
With Frax 1550™ and Frax 1940™ handpieces.
FDA clearance of Frax 1940 for pigmentation.
Exceed™ microneedling device introduced
Latest technology that’s quickly replacing dermal rollers and other anti-aging methods on the market.
Two PicoWay handpieces launched
730 nm and Resolve Fusion™ 532 nm
Syneron-Candela rebrands as Candela.
New global HQ in Marlborough, MA.
Nordlys™ platform introduced
High ROI fractional non-ablative resurfacing capabilities.
PicoWay Resolve Fusion and 4th wavelength introduced
The Vbeam Prima system with an advanced 595nm pulsed dye laser (PDL) and 1064nm wavelength, receives FDA clearance.
Syneron-Candela acquires Ellipse A/S adding renowned Ellipse IPL to portfolio.
APAX Partners acquires Syneron Candela.
PicoWay® Resolve Handpiece
Syneron Candela introduces the PicoWay Resolve handpiece with a 3rd wavelength.
CO2RE® Intima Handpiece
The CO2RE Intima system for feminine health is launched.
Profound system - the first long-pulse, temperature-controlled RF microneedling device, is launched.
PicoWay, a 2-wavelength laser platform is introduce.